The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
EXPN UPGRADE............ 08 Apr 2015 Experian PLC EXPN Credit Suisse Outperform 1,150.00 1,150.00 1,100.00 1,300.00 Upgrades SP TARGET 1300p
In here for a few - any clues to final results? - Plenty of broker optimism.
lol, i should have waited for the double dip.
a few, been waiting for a dip.
Res Ipsa loquitor
13 Feb 2015 Experian PLC EXPN Jefferies International Buy 1,195.00 1,199.00 1,240.00 1,340.00 Reiterates
04 Feb 2015 Experian PLC EXPN Citigroup Buy 1,171.00 1,185.00 1,410.00 1,410.00 Reiterates SP TARGET 1410p
Broker Buy Recos and Fundies for EXPN Experian....... 29 Jan 15 Nomura Buy 1,180.50 - 1,260.00 Retains 29 Jan 15 Deutsche Bank Buy 1,180.50 1,150.00 1,300.00 Reiterates 29 Jan 15 JP Morgan Cazenove Overweight 1,180.50 1,347.00 1,347.00 Reiterates 28 Jan 15 Liberum Capital Buy 1,180.50 1,230.00 1,230.00 Reiterates 16 Jan 15 Jefferies International Buy 1,180.50 1,200.00 1,240.00 Reiterate Experian PLC FORECASTS 2015 2016 Date Rec Pre-tax (£) EPS (p) DPS (p) Pre-tax (£) EPS (p) DPS (p) Exane BNP Paribas 02-02-15 HOLD 715.95 61.42 25.76 750.95 62.74 26.42 Shore Capital 30-01-15 BUY 820.76 62.80 26.48 865.27 64.32 28.27 Morningstar Equity Research 15-01-15 HOLD 640.66 61.98 24.79 700.64 65.93 25.98 2015 2016 Pre-tax (£) EPS (p) DPS (p) Pre-tax (£) EPS (p) DPS (p) Consensus 767.62 62.40 25.93 807.31 65.10 26.83 1 Month Change 20.51 2.11 0.91 -22.27 0.87 0.01 3 Month Change 52.42 4.25 1.83 31.34 3.51 1.20 GROWTH 2014 (A) 2015 (E) 2016 (E) Norm. EPS 144.88% 22.97% 4.32% DPS 10.38% 14.07% 3.47% INVESTMENT RATIOS 2014 (A) 2015 (E) 2016 (E) EBITDA £1,015.32m £1,121.11m £1,177.62m EBIT £713.73m £783.92m £842.28m Dividend Yield 1.95% 2.22% 2.30% Dividend Cover 2.23x 2.41x 2.43x PER 23.02x 18.72x 17.94x PEG 0.16f 0.82f 4.15f Net Asset Value PS -217.42p 217.95p 224.56p
<b>Experian buyback plans music to analysts’ ears</b> Citywire 30/1/2015 Shares in credit check company Experian (EXPN) have been boosted after the buyback plan was more positive than expected. Jefferies analyst Kean Marden retained his ‘buy’ recommendation and target price of £12.40 on the shares, which edged a penny lower to £11.83 yesterday. ‘Experian’s capital framework contained the buyback we predicted but was more positive than expected,’ he said. ‘Risk-adjusted hurdle rates and benchmarking organic/ inorganic investment against share repurchase is music to our ears… The increased focus on return on invested capital should support an ongoing buyback and more generous dividend. These characteristics are highly desirable in the current economic environment.
Experian broker views Date Broker Recommendation Price Old target price New target price Notes 29 Jan Nomura Buy 1,197.50 - 1,260.00 Retains 29 Jan Deutsche Bank Buy 1,197.50 1,150.00 1,300.00 Reiterates 29 Jan JP Morgan Cazenove Overweight 1,197.50 1,347.00 1,347.00 Reiterates 28 Jan Liberum Capital Buy 1,197.50 1,230.00 1,230.00 Reiterates
<b>Experian's cash generation a 'key strength', says Liberum</b> 28 January 2015 12:10 Broker Liberum reiterated its 'buy' rating on Experian stock after the information services firm announced an unexpected $600m (£394.7m) buyback, which amounts to 5% of its stock. On Wednesday, the FTSE 100 group announced a share repurchase programme after conducting a full capital framework review, pledging to return surplus capital to shareholders from time to time The evaluation concluded that given the group's strong cash generation acquisitions will still form part of the business growth mix, while dividend will remain in line with or ahead of earnings. "This new return guidance will be further supported by the growth initiatives [...] where we would expect focus on growth initiatives in credit services as well as plans to stabilise and improve its US consumer division," Liberum said in a note. The company also said it is adopting a new target leverage range of 2 to 2.5 times net debt to earnings before interest, tax, depreciation and amortisation (EBITDA), moving away from its previous target of 1.75 to 2 times net debt to EBITDA. "Experian's sustainable superior cash generation remains a key strength," Liberum added. Experian shares were up 3.00% to 1,200.00p at 12:06 on Wednesday.
FTSE 100 movers: Experian boosted by new growth strategy, Anglo disappoints with 2015 guidance Jack Pusey | Sharecast | 28 Jan, 2015 13:35 - Updated: 15:56 Credit-checking firm Experian was a high riser after unveiling an unexpected $600m share buyback and outlining plans to “deliver annual average growth in organic revenue in the mid-single digit range”. The company also said it has the potential for “strong growth” in earnings per share.
<b>Experian surprises with share buyback and new dividend ratio</b> Wed 28 January 2015 09:17 Credit checking group Experian has announced a $600m share buyback and made positive noises about growing its dividend, hidden among details of an investor seminar to be held on Wednesday afternoon. The FTSE 100 group said the repurchase programme of 5% of its shares had been decided following a full capital framework review. The review concluded that, given the group's strong cash generation, acquisitions will still be a key tenet of growth but that the strong cash profile "provides the potential to progress the ordinary dividend payout" in line with or ahead of earnings and a new target leverage range will be adopted of 2.0 times to 2.5 times net debt/EBITDA. "There is now scope to enhance the efficiency of the capital structure, whilst sustaining strong investment grade credit ratings and sufficient flexibility for future investment," the group said in its statement. The $600m buyback will be completed over 14 months, well ahead of the schedule. Broker Liberum said it expected a return to additional capital returns. "This new return guidance will be further supported by the growth initiatives expected to set out this afternoon, where we would expect focus on growth initiatives in credit services as well as plans to stabilise and improve its US consumer division."
28 Jan 2015 Experian PLC EXPN Liberum Capital Buy 1,209.00 1,165.00 1,230.00 1,230.00 Reiterates SP TARGET 1230p
EXPN Experian, Chart looking very bullish momentum very strong look for further gains med term . Investors day today should see Broker updates maybe upgrades. (im long) https://pbs.twimg.com/media/B8bflJ9CMAERjy6.jpg
Experian shares jump on solid trading: The largest credit checking agency in the world, Experian offers steady income and dividend growth for investors. The company’s shares rose more than 4% after it reported solid third quarter results. Experian said demand from corporate customers for credit checks remains strong with revenue up 6%, but this was offset by a 12% drop in consumers checking their credit scores. The core North American division, where Experian generates about half of its revenues, reported sales up 1% during the three months ended December 31. The most exciting growth had been coming from Latin America, but that has now been reversed by a slump in the Brazilian currency. Growth in Brazilian revenues is being more than offset by a sharp fall in the value of the country’s currency - the real. The demand for corporate credit checks in Brazil increased 6% during the period, while consumer credit checking was subdued along with the general economy. Meanwhile, the U.K.’s economic recovery helped Experian notch up a 2% increase in revenue, as demand increased from consumer and business lending sectors during the period. The U.K. and Ireland contributed another 20% to the group total, with the balance from Asia Pacific. The company said that expectations for the full year were unchanged. “We are confident of our ability to return Experian to top-line growth,” it said. Experian shares look fully priced, trading on 18 times forecast earnings. With a forecast dividend that yields 2.3%, and expected to increase by 7% during the next two years, they remain a hold. Experian at £11.21+56p Questor Says “Hold”.
http://www.investegate.co.uk/experian-plc/rns/half-yearly-financial-report/201411060700152855W/ That's more like it.
this for the divis except me and Questor. Should have sold it weeks ago but was too busy chatting to lego on another bb. Was the performance being blamed on a strong pound, a strong dollar. Oh what the heck when is the ex divi date.
As predicted - little dip was opportunity to get involved - see my entry last wednesday - fundamentals good and moving into health sector in US is good news.
Positive Points: Experian is buying Passport Health Communications Inc, a leading provider of data, analytics and software in the US healthcare payments market. The Chief Executive noted that "the acquisition of Passport Health will make us a clear leader in this high growth and attractive market." Although below some analyst forecasts, group organic revenue (excluding acquisitions) grew by 6%. Organic revenue growth was achieved across all regions and business lines. The Chief Executive noted that "for the second half, we expect organic revenue growth to be in a similar range as in the first half, and for the full year, we continue to expect modest margin improvement (at constant currency)." The group enjoys both product and geographical diversity. Experian's Consumer Information organisation operates 19 consumer credit bureaux maintaining information on over 740 million consumers. A progressive dividend policy continues to be pursued. The interim dividend was increased by 7%
Negative Points: Experian's acquisition of Passport Health Communications follows its $324 million deal to buy US fraud detection firm, 41st Parameter, last month. Group net debt increased by $218 million to $3.156 billion. Marketing Services for Latin America declined by 11%. The decline in revenue reflected some postponements by clients in Brazil and further weakness in the document process outsourcing business in Colombia, which was divested after the period end. Given the global reach of the company, this exposes it to foreign exchange risk. The depreciation of the Brazilian Real relative to the US dollar has impacted previously. Experian operates in a highly regulated environment. The company is subject to various regulations globally regarding the collection, protection, and use of consumer data. In addition, it is also subject to a degree of political risk, relying on legislation not only to open up new credit bureau geographies but also to protect its market position in existing markets. The company is exposed to a degree of acquisition risk if integration does not produce the desired financial results.
Financial Highlights: Total and organic revenue from continuing activities increased by 6% at constant exchange rates. At actual exchange rates, total revenue from continuing activities increased by 3%. Benchmark or adjusted profit before tax of rose 2% to $573 million. Interim dividend of 11.5 US cents per ordinary share, up 7%.
Half year results and acquisition: The news appeared to generate a degree of investor caution, with the share price down by over 5% in late-morning stockmarket trading. The global information services company announced that it is to buy Passport Health Communications Inc, a leading provider of data, analytics and software in the US healthcare payments market, subject to regulatory approval. The Chief Executive noted that "since entering the US healthcare payments market five years ago, we have steadily expanded our position. The acquisition of Passport Health will make us a clear leader in this high growth and attractive market. We will offer our clients in the US healthcare industry a competitive one-stop-shop to manage risk and to satisfy their payments requirements." Nonetheless, some analyst concern over the $850 million price tag of Passport was expressed, with worries that a previously announced $500 million share buy-back scheme will be terminated at the current $322 million (as of 30September 2013). Furthermore, organic revenue growth disappointed some analysts, with its Latin American business reporting a revenue decline in total continuing activities
I saw this todayas a good buying in opportunity - good cahnge to get on the coaster upwards.
Hello stranger Recognise the name, either from SAR, or my silly days in SOU or even worse PYC OInly bought in here last month, £10k for last years ISA, so smiling today